Abbott Laboratories

Abbott Laboratories

Health Care Equipment & Supplies
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

$179.1B

Market Cap • 9/23/2026

1900

(126 years)

Founded

1949

(77 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

1,7

P/S

3,8

P/EBITDA

16,6

P/OCF

18,1

P/FCF

22,9

P/E

33,5

BVPS

58,9

EPS

3,1

Market Cap

Market Cap

179,1B

EV

206,7B

EV/Revenue

4,4

EV/EBITDA

19,2

EV/EBIT

28,1

Payout

Dividend Per Share

2,4

Dividend Yield

2,4%

Buyback Yield

0,9%

Total Yield

3,3%

Dividend Yield 5Y

2,1%

Payout

78,5%

Retained Earnings

49,8B

Profitability

Gross Margin

56,6%

EBITDA Margin

23,2%

EBIT Margin

15,8%

Net Margin

11,6%

D&A/EBITDA

17,8%

R&D/Revenue

6,8%

Capex/Revenue

4,5%

Capex/D&A

60,4%

Capex/OCF

21%

SBC/OCF

7,2%

% PPE

11,7%

% Goodwill

32,3%

ROE

7%

ROIC

7%

Growth

CAGR Revenue 5Y

3%

CAGR Op. Income 5Y

-0,2%

CAGR Net Income 5Y

-3,2%

CAGR EPS 5Y

-2,7%

CAGR OCF 5Y

-1,4%

Leverage

N.D./EBITDA

2,5

Debt/Equity

0%

Current Ratio

1,4

Quick Ratio

0,8

Interest Coverage

959%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium